However, ZNF419 seemed to be a protective factor in BLCA, KIRC, PRAD and some other cancers because low ZNF419 expression was related to a good prognosis (analyzed by OS, DSS, and PFI). Here, ZNF419 is linked to prostate adenocarcinoma.